Modulation of cerebral catecholamine concentrations during hyperphenylalaninaemia

Area of Science:

• Neuroscience
• Biochemistry
• Developmental Biology

Background:

• Hyperphenylalaninemia, a condition characterized by elevated phenylalanine levels, can impact neurotransmitter synthesis.
• Dopamine and noradrenaline are critical catecholamines involved in various brain functions.

Purpose of the Study:

• To investigate the effects of hyperphenylalaninemia on cerebral dopamine and noradrenaline levels in developing rats.
• To explore the role of tyrosine in mitigating these neurochemical changes.

Main Methods:

• Induction of hyperphenylalaninemia in 7- and 11-day-old rats using alpha-methylphenylalanine and phenylalanine.
• Measurement of cerebral dopamine and noradrenaline concentrations.
• In vitro studies assessing tyrosine hydroxylase inhibition.

Main Results:

• Daily injections of alpha-methylphenylalanine plus phenylalanine decreased cerebral dopamine and noradrenaline by 20-40%.
• Both alpha-methylphenylalanine and phenylalanine individually depleted cerebral dopamine, with alpha-methylphenylalanine having a more pronounced effect.
• Increased brain tyrosine concentrations counteracted the dopamine depletion caused by excess phenylalanine.

Conclusions:

• Tyrosine hydroxylase inhibition is implicated as the mechanism for dopamine depletion in hyperphenylalaninemia.
• Tyrosine supplementation presents a theoretical basis for treating phenylketonuria by modulating the cerebral phenylalanine/tyrosine ratio.